Annual EBIT
-$59.28 M
-$3.73 M-6.72%
December 31, 2023
Summary
- As of February 8, 2025, OVID annual earnings before interest & taxes is -$59.28 million, with the most recent change of -$3.73 million (-6.72%) on December 31, 2023.
- During the last 3 years, OVID annual EBIT has risen by +$22.15 million (+27.20%).
- OVID annual EBIT is now -147.73% below its all-time high of $124.21 million, reached on December 31, 2021.
Performance
OVID EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$13.23 M
+$7.29 M+35.54%
September 30, 2024
Summary
- As of February 8, 2025, OVID quarterly earnings before interest & taxes is -$13.23 million, with the most recent change of +$7.29 million (+35.54%) on September 30, 2024.
- Over the past year, OVID quarterly EBIT has increased by +$4.96 million (+27.29%).
- OVID quarterly EBIT is now -107.49% below its all-time high of $176.56 million, reached on March 31, 2021.
Performance
OVID Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$69.35 M
-$1.20 M-1.76%
September 30, 2024
Summary
- As of February 8, 2025, OVID TTM earnings before interest & taxes is -$69.35 million, with the most recent change of -$1.20 million (-1.76%) on September 30, 2024.
- Over the past year, OVID TTM EBIT has dropped by -$10.07 million (-16.98%).
- OVID TTM EBIT is now -153.77% below its all-time high of $128.97 million, reached on September 30, 2021.
Performance
OVID TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
OVID EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.7% | +27.3% | -17.0% |
| 3 y3 years | +27.2% | +27.3% | -17.0% |
| 5 y5 years | -12.0% | +27.3% | -17.0% |
OVID EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -147.7% | at low | -9.9% | +49.8% | -155.8% | +0.5% |
| 5 y | 5-year | -147.7% | +27.2% | -107.5% | +49.8% | -153.8% | +14.8% |
| alltime | all time | -147.7% | +27.2% | -107.5% | +61.4% | -153.8% | +14.8% |
Ovid Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.23 M(-35.5%) | -$69.35 M(+1.8%) |
| Jun 2024 | - | -$20.52 M(+17.8%) | -$68.15 M(+10.3%) |
| Mar 2024 | - | -$17.42 M(-4.2%) | -$61.81 M(+4.3%) |
| Dec 2023 | -$59.28 M(+6.7%) | -$18.19 M(+51.2%) | -$59.28 M(+11.3%) |
| Sep 2023 | - | -$12.03 M(-15.1%) | -$53.27 M(-1.4%) |
| Jun 2023 | - | -$14.17 M(-4.8%) | -$54.04 M(-0.2%) |
| Mar 2023 | - | -$14.89 M(+22.3%) | -$54.17 M(-2.5%) |
| Dec 2022 | -$55.55 M(-144.7%) | -$12.17 M(-4.9%) | -$55.55 M(-20.3%) |
| Sep 2022 | - | -$12.80 M(-10.5%) | -$69.73 M(+1.6%) |
| Jun 2022 | - | -$14.30 M(-12.1%) | -$68.60 M(-0.0%) |
| Mar 2022 | - | -$16.27 M(-38.3%) | -$68.61 M(-155.2%) |
| Dec 2021 | $124.21 M(-252.5%) | -$26.35 M(+125.6%) | $124.21 M(-3.7%) |
| Sep 2021 | - | -$11.68 M(-18.4%) | $128.97 M(+3.8%) |
| Jun 2021 | - | -$14.31 M(-108.1%) | $124.25 M(+7.6%) |
| Mar 2021 | - | $176.56 M(-917.7%) | $115.42 M(-241.7%) |
| Dec 2020 | -$81.43 M | -$21.59 M(+31.6%) | -$81.43 M(+5.6%) |
| Sep 2020 | - | -$16.40 M(-29.1%) | -$77.11 M(-0.5%) |
| Jun 2020 | - | -$23.14 M(+14.0%) | -$77.47 M(+14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$20.29 M(+17.5%) | -$67.65 M(+10.2%) |
| Dec 2019 | -$61.41 M(+16.0%) | -$17.27 M(+3.0%) | -$61.41 M(+7.2%) |
| Sep 2019 | - | -$16.77 M(+25.8%) | -$57.27 M(+6.7%) |
| Jun 2019 | - | -$13.32 M(-5.2%) | -$53.68 M(+0.2%) |
| Mar 2019 | - | -$14.05 M(+7.1%) | -$53.57 M(+1.2%) |
| Dec 2018 | -$52.93 M(-18.6%) | -$13.13 M(-0.4%) | -$52.94 M(+4.1%) |
| Sep 2018 | - | -$13.18 M(-0.3%) | -$50.86 M(+8.0%) |
| Jun 2018 | - | -$13.21 M(-1.6%) | -$47.10 M(+6.6%) |
| Mar 2018 | - | -$13.43 M(+21.6%) | -$44.17 M(-32.0%) |
| Dec 2017 | -$65.01 M(+188.5%) | -$11.05 M(+17.4%) | -$65.01 M(+5.6%) |
| Sep 2017 | - | -$9.41 M(-8.5%) | -$61.55 M(+6.2%) |
| Jun 2017 | - | -$10.29 M(-70.0%) | -$57.95 M(+9.2%) |
| Mar 2017 | - | -$34.26 M(+351.5%) | -$53.08 M(+135.6%) |
| Dec 2016 | -$22.54 M(+70.8%) | -$7.59 M(+30.5%) | -$22.53 M(+50.8%) |
| Sep 2016 | - | -$5.81 M(+7.4%) | -$14.95 M(+63.7%) |
| Jun 2016 | - | -$5.42 M(+45.8%) | -$9.13 M(+145.8%) |
| Mar 2016 | - | -$3.71 M | -$3.71 M |
| Dec 2015 | -$13.19 M | - | - |
FAQ
- What is Ovid Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ovid Therapeutics?
- What is Ovid Therapeutics annual EBIT year-on-year change?
- What is Ovid Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly EBIT year-on-year change?
- What is Ovid Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ovid Therapeutics?
- What is Ovid Therapeutics TTM EBIT year-on-year change?
What is Ovid Therapeutics annual earnings before interest & taxes?
The current annual EBIT of OVID is -$59.28 M
What is the all time high annual EBIT for Ovid Therapeutics?
Ovid Therapeutics all-time high annual earnings before interest & taxes is $124.21 M
What is Ovid Therapeutics annual EBIT year-on-year change?
Over the past year, OVID annual earnings before interest & taxes has changed by -$3.73 M (-6.72%)
What is Ovid Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of OVID is -$13.23 M
What is the all time high quarterly EBIT for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly earnings before interest & taxes is $176.56 M
What is Ovid Therapeutics quarterly EBIT year-on-year change?
Over the past year, OVID quarterly earnings before interest & taxes has changed by +$4.96 M (+27.29%)
What is Ovid Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of OVID is -$69.35 M
What is the all time high TTM EBIT for Ovid Therapeutics?
Ovid Therapeutics all-time high TTM earnings before interest & taxes is $128.97 M
What is Ovid Therapeutics TTM EBIT year-on-year change?
Over the past year, OVID TTM earnings before interest & taxes has changed by -$10.07 M (-16.98%)